Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?

Open Access

Peer-reviewed

Research Article

Ohseong Kwon,

Affiliation Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
⨯
Tae Jin Kim,

Affiliation Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
⨯
In Jae Lee,

Affiliation Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
⨯
Seok-Soo Byun,

Affiliation Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
⨯
Sang Eun Lee,

Affiliation Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
⨯
Sung Kyu Hong

* E-mail: hsk823@chol.com

Affiliation Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea
⨯

Reader Comments (0)

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Disease surveillance
Is the Subject Area "Disease surveillance" applicable to this article?

Thanks for your feedback.